Period Ending | Jun 29, 2012 | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 |
---|
Total Revenue
|
31,575,000
|
31,822,000
|
32,503,000
|
31,478,000
| Cost of Revenue | 12,369,000 | 12,913,000 | 17,474,000 | 14,331,000 | |
Gross Profit
|
19,206,000
|
18,909,000
|
15,029,000
|
17,147,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 7,890,000 | 8,248,000 | 16,536,000 | 6,294,000 |
|
Non Recurring |
-
|
-
| 2,910,000 |
-
|
|
Others | 4,499,000 | 4,560,000 | 4,573,000 | 4,618,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
6,817,000
|
6,101,000
|
(8,990,000)
|
6,235,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 23,000 | 52,000 | 117,000 | 46,000 |
|
Earnings Before Interest And Taxes | 6,972,000 | 6,376,000 | (8,738,000) | 6,474,000 |
|
Interest Expense | 941,000 | 859,000 | 952,000 | 889,000 |
|
Income Before Tax | 6,031,000 | 5,517,000 | (9,690,000) | 5,585,000 |
|
Income Tax Expense | 2,066,000 | 1,865,000 | (3,062,000) | 1,899,000 |
|
Minority Interest | (63,000) | (68,000) | (50,000) | (63,000) |
|
|
|
Net Income From Continuing Ops | 4,034,000 | 3,807,000 | (6,628,000) | 3,357,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
3,902,000
|
3,584,000
|
(6,678,000)
|
3,623,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
3,902,000
|
3,584,000
|
(6,678,000)
|
3,623,000
|
|